IRIS is one a common and potentially serious complication occurring in HIV infected patients being treated for tuberculosis (TB) using cART. A role of adaptive immunity has been suggested in the onset of IRIS, whereas the role of NK cells has not yet been explored. We aimed to examine the involvement of NK cell in the onset of IRIS in HIV-infected patients with TB and to identify predictive markers of IRIS. 128 HIV-infected patients with TB from the CAMELIA trial were enrolled in Cambodia. Thirty-seven of the 128 patients developed IRIS. At inclusion, patients had low CD4 cell counts (27cells/mm 3 ) and high plasma viral load (5.76 and 5.50log/ml in IRIS and non IRIS patients, respectively). At baseline, NK cell degranulation capacity was significantly higher in IRIS patients than in non IRIS patients (9.6% vs 6.38%, p<0.005). At IRIS onset, degranulation capacity did not differ between patients whereas activating receptor expression was lower in IRIS patients. Patients with degranulation level >10.84% had higher risk of IRIS (log-rank test: p=0.002). Degranulation 
Summary
IRIS is one a common and potentially serious complication occurring in HIV infected patients being treated for tuberculosis (TB) using cART. A role of adaptive immunity has been suggested in the onset of IRIS, whereas the role of NK cells has not yet been explored. We aimed to examine the involvement of NK cell in the onset of IRIS in HIV-infected patients with TB and to identify predictive markers of IRIS. 128 HIV-infected patients with TB from the CAMELIA trial were enrolled in Cambodia. Thirty-seven of the 128 patients developed IRIS. At inclusion, patients had low CD4 cell counts (27cells/mm 3 ) and high plasma viral load (5.76 and 5.50log/ml in IRIS and non IRIS patients, respectively). At baseline, NK cell degranulation capacity was significantly higher in IRIS patients than in non IRIS patients (9.6% vs 6.38%, p<0.005). At IRIS onset, degranulation capacity did not differ between patients whereas activating receptor expression was lower in IRIS patients. Patients with degranulation level >10.84% had higher risk of IRIS (log-rank test: p=0.002). Degranulation . NK cells appear to play an important role in HIV infection 7, 8 The aim of this study was to investigate the involvement of NK cells in the occurrence of TB-IRIS in HIV-infected patients with TB who started cART. Moreover, we tried to identify markers of innate immunity that could predict the occurrence of IRIS in this setting.
Patients and Methods

Patients
This work was a study linked to the CAMELIA clinical trial (ANRS 1295-CIPRA KH 001-DAIDS-ES ID 10425) that showed markedly improved survival when cART was started 2 weeks versus 8 weeks after TB treatment initiation 19 . From June 2006 to August 2008, 147 HIV-infected adults with TB enrolled in the CAMELIA trial in Cambodia gave their specific signed consent to enter this study. CAMELIA was a prospective, randomized, multicenter, 
Phenotypic studies of NK cells
All phenotypic studies were done on fresh whole blood using a four-color BD FACScalibur II 
Degranulation (CD107a expression) assay and intracellular cytokine staining
CD107a expression on NK cells and the ICS-based assay were used to measure degranulation and cytokine expression, as previously described 12 . PBMC were isolated from fresh whole 
Statistical analysis
Baseline characteristics were compared across groups using the ch-2 test for categorical variables and a t-test or a non-parametric test depending on the sample size. Degranulation at baseline was first compared across the 5 groups using Kruskall-Wallis for multiple group comparisons. If the test showed a significant difference, two by two comparisons were The association between NK cell activity before cART initiation and occurrence of IRIS was studied by constructing Kaplan-Meier curves. Each factor was subdivided into four categories, based on the 25 th , 50 th and 75 th percentiles, with these percentiles being estimated when both IRIS and Non IRIS patients are combined and the curves were compared using the log-rank test. The effect of each factor was also quantified in a Cox model, the proportional hazard assumption was validated by the test based on Schoenfeld's residuals.
Role of the funding source
The French National Agency for AIDS and Hepatitis Research (ANRS) funded this study (ANRS 12153 study). The Scientific Committee, sponsored by ANRS, designed this study and oversaw the statistical analysis.
Results
Patients
Of the 147 HIV+/TB+ patients from Camelia trial initially enrolled in this NK cell study, 19
were excluded from the final analysis, for the following reasons: 10 patients had no follow-up on cART, 5 had suspected TB-IRIS that was not confirmed after review, 2 had TB paradoxical reactions before cART initiation, and 2 patients initiated cART before scheduled date. Of the remaining 128 patients, 37 had confirmed TB-IRIS. Of the 63 HIV+/TBcontrols, 14 were excluded, for the following reasons: 9 had no follow-up on cART and 5
were not ART-naïve and/or had ARV resistance mutations at enrolment. . At IRIS onset there was no significant difference in NK cell subsets between HIV+/TB+ patients with and without IRIS (data not shown).
Activation and receptor expression on NK cells from IRIS and non IRIS patients
Before cART initiation, CD69 expression was higher on NK cells from HIV+/TB+ patients than in the controls (data not shown). In contrast, we found no difference in NK cell receptor expression between HIV+/TB+ patients with and without IRIS (data not shown). Lower expression of natural cytotoxic receptors (NKp30, NKp44, NKp46) was found in HIV-1- When the total degranulation level between patients with and without disseminated TB was compared, we did not find evidence of a difference (see Table 3 , supplementary data). We also looked for a correlation between total degranulation capacity of NK cells at baseline and other parameters (CD4 and viral load) and no significant correlation was found (data not shown).
At the time of IRIS, degranulation capacity increased in stimulated NK cells from HIV+/TB+ patients without IRIS ( figure 1A and (Table 4A and B, respectively, supplementary data).
Total stimulated NK cell degranulation at baseline correlates with the risk of TB IRIS
Kaplan-Meier estimates showed that the risk of IRIS was influenced by the level of stimulated NK cell degranulation at baseline (log-rank test: p=0.002). Moreover, in patients with total NK degranulation >10.84%, all IRIS occurred within 8 weeks from cART initiation (median = 14 days) after starting cART, indicating that higher NK cell activity may be associated with early-onset IRIS. Total NK degranulation at baseline was the most important determinant of the risk of IRIS, which was 4-fold higher in patients with total NK degranulation >10.84% . In univariate analysis, age and disseminated TB were also significantly associated with the risk of IRIS (data not shown). When these two factors and total NK degranulation were entered in a multivariate Cox model, they all remained significantly associated with the risk of IRIS. After adjustment on age and disseminated TB, patients with total NK degranulation >10.84 had more than a 4-fold increase in risk of IRIS (adjusted HR: 4.30 (95% CI: 1.60 -11.57)).
Discussion
We examined the potential role of NK cells in the occurrence of IRIS in HIV+/TB+ patients participating in a randomized clinical trial. We found that HIV+/TB+ patients who developed
IRIS after cART initiation exhibited phenotypic and functional differences in their NK cell
For personal use only. on May 29, 2017. by guest www.bloodjournal.org From compartments relative to their IRIS-free counterparts. Importantly, patients who developed IRIS had significantly higher levels of NK cell degranulation before cART initiation, indicating that NK cell degranulation might serve as a predictive marker of IRIS. At the time of IRIS, degranulation activity was similar in the two groups, but differences were noted in the expression of NK cell receptors, and especially activating receptors. A role of NK cells in unmasking TB-related IRIS in HIV infected has been also suggested in a recent report 18 .
To understand the role of NK cells in cART-induced immune reconstitution and in the onset of TB-IRIS, both NK cytotoxic activity and the interaction of these cells with other immune components against wide range of opportunistic pathogens including TB must be considered.
NK cells engage in cross-talk with other immune cells, including CD4 T cells, in order to
promote adaptive immune responses 16, 21 . Increased CD4 T cell activation before cART introduction has been reported in HIV+/TB+ patients 22 and it has been suggested that this activation is driven by specific antigen responses, due to a higher antigen load or an imbalance in effector responses 22 . 
